Numinus to Host Q2 2023 Results Conference Call on April 13,...

Apex Labs Meets Endpoints in First-of-its-Kind Take Home Microdose Psilocybin Clinical...

Opinions | Why Reinvent the Wheel When You Can Amplify the...

PharmaTher Holdings Announces Update of Type C Meeting with the FDA...

BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug...

PT401 – The Self-Entropic Broadening Theory: Understanding The Psychedelic State and...

Field Trip’s Downfall: Too Early, Too Aggressive, Too Extravagant?

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use...

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion...

Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia

Load more